VNRX — VolitionRX Ltd
$0.1741+2.96%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for VNRX in the TickerWise workspace.
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: New York Stock Exchange Arca
- Employees: 85
- Website: https://volition.com
Latest SEC filings for VNRX
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.